
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion.image/iStock
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion
Sanstar Ltd has submitted its draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI) in anticipation of an upcoming initial public offering (IPO). This Ahmedabad-based enterprise specializes in producing plant-based specialty products and ingredient solutions utilized across various industrial, animal nutrition, and food applications within India.
In this exciting development, Sanstar Limited’s IPO encompasses an offer for sale (OFS) by selling shareholders, involving up to 8 million shares, and a fresh issue of up to 40 million shares. The company may also consider a pre-IPO placement of up to 4 million shares, contingent upon discussions with the Book Running Lead Manager (BRLM). The face value of a company share is ₹2.
The proposed utilization of fresh issue proceeds includes funding part of the capital expenditure required for expanding the Dhule facility, amounting to approximately ₹182 crores. Additionally, the remaining net proceeds, up to ₹100 crores, are earmarked for specific borrowing repayment and/or prepayment. Any net proceeds beyond expenses will be directed towards general corporate needs and issue costs.
In the fiscal year 2023, the company reported consolidated revenue of approximately ₹1,180 crores, with an EBITDA of about ₹73 crores and a Profit After Tax (PAT) of roughly ₹42 crores. The company’s Return on Equity (ROE) and Return on Capital Employed (ROCE) stood at approximately 28% and 24%, respectively. On a stand-alone basis, revenue, EBITDA, and PAT demonstrated a Compound Annual Growth Rate (CAGR) of around 57%, 39%, and 71%, respectively, between FY21 and FY23.
Sanstar boasts a global presence, exporting its products to over 45 nations across the Middle East, Africa, Asia, Americas, Europe, and Oceania. Notably, more than 30% of the company’s total revenue is derived from exports. The company’s Kutch facility holds registration with the US Food and Drug Administration (USFDA), underlining its commitment to quality standards.
Sanstar Ltd Files IPO Proposal with SEBI for Plant-Based Products Expansion:In case of rectification of any error in article , Visit on Correction Policy & Register your Query:
Latest Posts
- MLA Doda East Mehraj Malik Seeks Restoration of Escort Vehicle, Cites Security Concerns
June 4, 2026 | Breaking News, Jammu Kashmir, Politics - Miraj Cinemas pays tribute to its Managing Director, Shri Bhuvanesh Mendiratta
June 4, 2026 | Breaking News, Entertainment, Press Release - Liquor Ban in Jammu Kashmir: Committee Constituted to Examine the Possibility of Ban says Minister Javed Rana
June 4, 2026 | Breaking News, India - Surprisingly, Expelled Trinamool Rebel Ritabrata Banerjee Becomes Leader of Opposition in Bengal
June 3, 2026 | Breaking News, India, Politics - Donald Trump-Benjamin Netanyahu Relationship Under Growing Strain Amid Iran War
June 3, 2026 | Breaking News, Politics, World - Iran Fires Missiles Toward Kuwait and Bahrain After US Strikes Qeshm Island
June 3, 2026 | Breaking News, Politics, World - All India 16th Gufran Memorial T20 Tournament To Begin Tonight at Sports Stadium Doda
June 3, 2026 | Breaking News, Doda, Jammu Kashmir - Accident in Doda; 5 Injured
June 2, 2026 | Breaking News, India, Jammu Kashmir - Russia Strikes Ukraine; 9 Killed, Dozens Injured
June 2, 2026 | Breaking News, World - Home Ministry Amends Immigration and Foreigners Rules, 2025
June 2, 2026 | Breaking News, India, World